Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Jilg

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
Lancet (London, England)|August 25, 1984
Hepatitis B vaccination: how long does protection last?W Jilg, M Schmidt, F Deinhardt, et al.
Zeitschrift Fur Gastroenterologie|January 13, 2011
[Autochthonous hepatitis E-virus infection as cause of acute hepatitis in Germany - a case report]R Veitt, M Reichardt, J Wenzel, et al.
Gene|January 1, 1986
Expression of the Epstein-Barr virus major membrane proteins in Chinese hamster ovary cellsM Motz, G Deby, W Jilg, et al.
Journal of Virological Methods|December 1, 1990
Identification of type A and B isolates of Epstein-Barr virus by polymerase chain reactionW Jilg, E Sieger, P Alliger, et al.
Lancet (London, England)|October 27, 1984
Persistence of anti-HBs after intradermal inoculation of reduced doses of hepatitis B vaccineG Zoulek, B Lorbeer, W Jilg, et al.
Deutsche Medizinische Wochenschrift (1946)|February 8, 1985
[Persistence of antibodies against hepatitis B surface antigens after vaccination against hepatitis B]W Jilg, M Schmidt, R Zachoval, et al.
Lancet (London, England)|March 10, 1984
Antibody responses and skin reactivity after intradermal hepatitis B virus vaccineG Zoulek, B Lorbeer, W Jilg, et al.
Infection|February 14, 2007
Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccinationI Kleiter, W Jilg, U Bogdahn, et al.
Journal of Medical Virology|January 1, 1984
Evaluation of a reduced dose of hepatitis B vaccine administered intradermallyG Zoulek, B Lorbeer, W Jilg, et al.
European Journal of Epidemiology|June 9, 2000
The economic burden of hepatitis B in GermanyS Harbarth, T Szucs, K Berger, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Lancet (London, England)|August 25, 1984
Hepatitis B vaccination: how long does protection last?W Jilg, M Schmidt, F Deinhardt, et al.
Zeitschrift Fur Gastroenterologie|January 13, 2011
[Autochthonous hepatitis E-virus infection as cause of acute hepatitis in Germany - a case report]R Veitt, M Reichardt, J Wenzel, et al.
Gene|January 1, 1986
Expression of the Epstein-Barr virus major membrane proteins in Chinese hamster ovary cellsM Motz, G Deby, W Jilg, et al.
Journal of Virological Methods|December 1, 1990
Identification of type A and B isolates of Epstein-Barr virus by polymerase chain reactionW Jilg, E Sieger, P Alliger, et al.
Lancet (London, England)|October 27, 1984
Persistence of anti-HBs after intradermal inoculation of reduced doses of hepatitis B vaccineG Zoulek, B Lorbeer, W Jilg, et al.
Deutsche Medizinische Wochenschrift (1946)|February 8, 1985
[Persistence of antibodies against hepatitis B surface antigens after vaccination against hepatitis B]W Jilg, M Schmidt, R Zachoval, et al.
Lancet (London, England)|March 10, 1984
Antibody responses and skin reactivity after intradermal hepatitis B virus vaccineG Zoulek, B Lorbeer, W Jilg, et al.
Infection|February 14, 2007
Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccinationI Kleiter, W Jilg, U Bogdahn, et al.
Journal of Medical Virology|January 1, 1984
Evaluation of a reduced dose of hepatitis B vaccine administered intradermallyG Zoulek, B Lorbeer, W Jilg, et al.
European Journal of Epidemiology|June 9, 2000
The economic burden of hepatitis B in GermanyS Harbarth, T Szucs, K Berger, et al.
Pageof 15